AAAAAA

   
Results: 1-25 | 26-34 |
Results: 26-34/34
RIBOZYME AND ANTISENSE DNA REGULATION OF BCR ABL EXPRESSION IN CML PATIENTS/
Authors: KEARNEY PP WRIGHT LA MILLIKEN S BIGGS JC WILSON SB
Citation: Pp. Kearney et al., RIBOZYME AND ANTISENSE DNA REGULATION OF BCR ABL EXPRESSION IN CML PATIENTS/, Journal of cellular biochemistry, 1994, pp. 233-233
A PROSPECTIVE DOUBLE-BLIND TRIAL TO EVALUATE THE EFFECT OF HUMAN RECOMBINANT ERYTHROPOIETIN (RHU EPO) IN PATIENTS UNDERGOING MATCHED ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO BMT)
Authors: BIGGS JC DOWNS K WORTHINGTON R ATKINSON K DODDS A
Citation: Jc. Biggs et al., A PROSPECTIVE DOUBLE-BLIND TRIAL TO EVALUATE THE EFFECT OF HUMAN RECOMBINANT ERYTHROPOIETIN (RHU EPO) IN PATIENTS UNDERGOING MATCHED ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO BMT), Experimental hematology, 21(8), 1993, pp. 1172-1172
PRODUCTION OF A FUNCTIONAL SINGLE-CHAIN FV FRAGMENT FROM THE PAN-LEUKOCYTE ANTIBODY WM65 USING SPLICING BY ASYMMETRIC PCR
Authors: WARD RL HAWKINS NJ WAKEFIELD D ATKINSON K BIGGS JC
Citation: Rl. Ward et al., PRODUCTION OF A FUNCTIONAL SINGLE-CHAIN FV FRAGMENT FROM THE PAN-LEUKOCYTE ANTIBODY WM65 USING SPLICING BY ASYMMETRIC PCR, Experimental hematology, 21(5), 1993, pp. 660-664
OUTCOME AFTER ALLOGENEIC BONE-MARROW TRANSPLANT FOR LEUKEMIA IN OLDERADULTS
Authors: RINGDEN O HOROWITZ MM GALE RP BIGGS JC GAJEWSKI J RIMM AA SPECK B VEUMSTONE JA DEWITTE T BORTIN MM
Citation: O. Ringden et al., OUTCOME AFTER ALLOGENEIC BONE-MARROW TRANSPLANT FOR LEUKEMIA IN OLDERADULTS, JAMA, the journal of the American Medical Association, 270(1), 1993, pp. 57-60
TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH ALLOGENEIC BONE-MARROWTRANSPLANTATION AFTER PREPARATION WITH BUSULFAN AND CYCLOPHOSPHAMIDE (BUCY2) - AN UPDATE
Authors: BRODSKY I BIGGS JC SZER J CRILLEY P ATKINSON K DOWNS K DODDS A CONCANNON AJ AVALOS BR TUTSCHKA P KAPOOR N TOPOLSKY D BULOVA SI COPELAN EA
Citation: I. Brodsky et al., TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH ALLOGENEIC BONE-MARROWTRANSPLANTATION AFTER PREPARATION WITH BUSULFAN AND CYCLOPHOSPHAMIDE (BUCY2) - AN UPDATE, Seminars in oncology, 20(4), 1993, pp. 27-31
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA, ACUTE LYMPHOCYTIC-LEUKEMIA, AND MULTIPLE-MYELOMA FOLLOWING PREPARATION WITH BUSULFAN AND CYCLOPHOSPHAMIDE (BUCY2)
Authors: COPELAN EA BIGGS JC SZER J THOMPSON JM CRILLEY P BRODSKY I KLEIN JL KAPOOR N HARMAN GS AVALOS BR
Citation: Ea. Copelan et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA, ACUTE LYMPHOCYTIC-LEUKEMIA, AND MULTIPLE-MYELOMA FOLLOWING PREPARATION WITH BUSULFAN AND CYCLOPHOSPHAMIDE (BUCY2), Seminars in oncology, 20(4), 1993, pp. 33-38
INCIDENCE OF VENOOCCLUSIVE DISEASE OF THE LIVER (VOD) AFTER MARROW CONDITIONING WITH BUSULFAN AND 2 DAYS OF CYCLOPHOSPHAMIDE (BUCY2)
Authors: STYLER M BIGGS JC TOPOLSKY D ATKINSON K BULOVA S DOWNS K KOZUCH P BRODSKY I CRILLEY P
Citation: M. Styler et al., INCIDENCE OF VENOOCCLUSIVE DISEASE OF THE LIVER (VOD) AFTER MARROW CONDITIONING WITH BUSULFAN AND 2 DAYS OF CYCLOPHOSPHAMIDE (BUCY2), Blood, 82(10), 1993, pp. 10000642-10000642
CLINICAL ANALYSIS OF 125 PATIENTS WITH THE LUPUS ANTICOAGULANT
Authors: MORGAN M DOWNS K CHESTERMAN CN BIGGS JC
Citation: M. Morgan et al., CLINICAL ANALYSIS OF 125 PATIENTS WITH THE LUPUS ANTICOAGULANT, Australian and New Zealand Journal of Medicine, 23(2), 1993, pp. 151-156
CHANGING RESULTS OF HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATIONIN PATIENTS WITH HEMATOLOGICAL MALIGNANCY DURING THE PERIOD 1981-1990
Authors: ATKINSON K BIGGS JC CONCANNON AJ DODDS AJ MILLIKEN S DOWNS K MARSHALL G WILSON F YOUNG S ASHBY M MORGAN G HARKNESS J
Citation: K. Atkinson et al., CHANGING RESULTS OF HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATIONIN PATIENTS WITH HEMATOLOGICAL MALIGNANCY DURING THE PERIOD 1981-1990, Australian and New Zealand Journal of Medicine, 23(2), 1993, pp. 181-186
Risultati: 1-25 | 26-34 |